GH Research (GHRS) Amortization (2020 - 2025)
GH Research (GHRS) recorded quarterly Amortization of $2.3 million in Q4 2025, down 93.38% quarter-over-quarter from $34.0 million in Q4 2024, and down 93.38% on a YoY basis from $34.0 million in Q4 2024.
GH Research (GHRS) Amortization (2020 - 2025) Analysis & Trends
GH Research's Amortization history runs 5 years deep, the most recent figure standing at $2.3 million for Q4 2025.
- In Q4 2025, Amortization fell 93.38% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $2.3 million (down 93.38% YoY), while the FY2025 annual figure was $2.3 million, down 93.38% from the prior year.
- Amortization was $2.3 million for Q4 2025 at GH Research, down from $34.0 million in the prior quarter.
- In the past five years, Amortization ranged from a high of $291.4 million in Q3 2021 to a low of $163000.0 in Q4 2022.
- Historically, Amortization has averaged $121.0 million across 4 years, with a median of $34.0 million in 2024.
- The sharpest annual moves came in 2021 and 2022: Amortization surged 57246.67% in 2021, then slumped 99.94% in 2022.
- A 4-year view of Amortization shows it stood at $277.2 million in 2021, then plunged by 99.94% to $163000.0 in 2022, then surged by 20788.34% to $34.0 million in 2024, then sank by 93.38% to $2.3 million in 2025.
- The last three Amortization figures came in at $2.3 million (Q4 2025), $34.0 million (Q4 2024), and $163000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.25 Mn |
| Dec 31, 2025 | 2.25 Mn |
| Dec 31, 2024 | 34.05 Mn |
| Dec 31, 2024 | 34.05 Mn |
| Dec 31, 2022 | 163,000.00 |
| Dec 31, 2022 | 163,000.00 |
| Dec 31, 2021 | 277.18 Mn |
| Dec 31, 2021 | 277.18 Mn |
| Sep 30, 2021 | 291.45 Mn |
| Sep 30, 2021 | 291.45 Mn |
| Dec 31, 2020 | 5.67 Mn |
| Dec 31, 2020 | 5.67 Mn |
| Sep 30, 2020 | -510,000.00 |
| Sep 30, 2020 | -510,000.00 |